Matthew Stanton, CHIEF SCIENTIFIC OFFICER at Generation Bio Co. (GBIO), sold 1,500 shares at $28.03 ($42K) on 2021-04-16, disclosed to the SEC on 2021-04-20.
Scheduled sale ($42k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GBIO | SELL | 2021-08-25 | $38K | — | Filing → |
| GBIO | SELL | 2021-08-11 | $34K | — | Filing → |
| GBIO | SELL | 2021-07-14 | $75K | — | Filing → |